Impact of Early Response to First-line Anti-PD-1 Monotherapy in Patients With Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma, Assessed by 18F-FDG PET/CT
Clinical trial NCT07448727 · RECRUITING
Trial details
- NCT number
- NCT07448727
- Sponsor
- University of Rome Tor Vergata
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-11-20
- Primary completion
- 2026-12-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.